Please login to the form below

37

Revenue 2017

Invega Sustenna/Xeplion/Invega Trinza

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Invega Sustenna/Xeplion/Invega Trinza was produced by Roche.

J&J files three-monthly schizophrenia drug in Europe

J&J sells a once-monthly version of paliperidone as Invega Sustenna in the US and Xeplion in Europe, but the reduced dosing frequency could give the franchise a competitive advantage ... Xeplion/Invega Sustenna is already a big earner for J&J, with sales

FDA approves J&J’s schizophrenia drug Invega Trinza

The FDA has approved Johnson &Johnson's Invega Trinza (three-month paliperidone palmitate) for schizophrenia. ... Invega Sustenna, which is marketed as Xeplion in Europe, saw its 2014 sales grow by 27% to $1.6bn and J&J will be hopig Invega Trinza will

Result pages: 1

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Featured jobs

Sudler London - Senior Medical Writer: Competitive

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Account Director or Senior Account Director: Salary TBC

Associate Scientific Director: Salary TBC

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Market Access Consultant - Greater Manchester: Negotiable

Senior Writer, Healthcare Advertising, London: Excellent package

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Graduate Scientific Editor: DOE

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Senior Medical Writer, MedComms Agency: Salary TBC

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Account Director, Healthcare Advertising Agency: Salary TBC

Healthcare PR Senior Account Manager: Salary TBC

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Systematic Review Lead- London: Negotiable

Sudler London - Account Director: Competitive

Senior Training Manager - Surrey: Competitive Salary &Bonus

Senior Account Manager – Healthcare Advertising: Salary TBC

Integrated Brand/ Digital Senior Account Director, London: Excellent package

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....